- Trials with a EudraCT protocol (725)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (4,519)
725 result(s) found for: GI.
Displaying page 1 of 37.
EudraCT Number: 2007-001928-12 | Sponsor Protocol Number: 17/2007/U/Sper | Start Date*: 2007-04-23 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Contrast enhanced ultrasonography effectiveness in early evaluating of the response to the Sunitinib in the patients with advanced GIST. A pilot study | |||||||||||||
Medical condition: Gastrointestinal stromal tumor (GIST) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004624-41 | Sponsor Protocol Number: 24092020 | Start Date*: 2021-07-07 | ||||||||||||||||
Sponsor Name:Zealand University Hospital | ||||||||||||||||||
Full Title: Calcium Electroporation for Malignant GI Bleeding – a randomized controlled trial | ||||||||||||||||||
Medical condition: Malignant gastrointestinal bleeding | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-015070-35 | Sponsor Protocol Number: RB 09.091 | Start Date*: 2010-05-18 | |||||||||||
Sponsor Name:CHRU de BREST | |||||||||||||
Full Title: Evaluation de l'intérêt d'une préparation de l'intestin Grèle par polyéthylèneglycol pour l'exploration par vidéocapsule endoscopique des saignements digestifs inexpliqués | |||||||||||||
Medical condition: Saignement digestif inexpliqué extériorisé ou non associé à une anémie | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017819-16 | Sponsor Protocol Number: OP-GIB | Start Date*: 2011-08-22 | ||||||||||||||||
Sponsor Name:Juan Cordoba | ||||||||||||||||||
Full Title: Efectos de la administración de ornitina-fenilacetato (OCR-002) en pacientes con cirrosis y hemorragia digestiva alta. Effects of the administration of ornithine phenylacetate (OP, OCR-002) in pati... | ||||||||||||||||||
Medical condition: Hemorragia digestiva en pacientes con cirrosis hepática | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-024309-11 | Sponsor Protocol Number: ERITRO2011 | Start Date*: 2011-03-16 | |||||||||||
Sponsor Name:JOSEP MARIA BOTARGUES BOTÉ | |||||||||||||
Full Title: Eritromicina versus lavados por sonda nasogástrica para mejorar la calidad visual de la endoscopia digestiva en pacientes con hemorragia digestiva alta. Ensayo clínico aleatorizado | |||||||||||||
Medical condition: HEMORRAGIA DIGESTIVA ALTA | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000065-38 | Sponsor Protocol Number: ASL607LIOM01 COMET-GI | Start Date*: 2007-02-28 | |||||||||||
Sponsor Name:AZIENDA USL 6 LIVORNO ZONA LIVORNESE | |||||||||||||
Full Title: METRONOMIC CHEMOTHERAPY WITH URACIL/TEGAFUR (UFT), CYCLOPHOSPHAMIDE (CTX) AND CELECOXIB IN PRETREATED PATIENTS WITH ADVANCED GASTROINTESTINAL MALIGNANCIES: A PILOT CLINICAL STUDY WITH PHARMACOKINET... | |||||||||||||
Medical condition: PATIENTS WITH ADVANCED GASTROINTESTINAL MALIGNANCIES | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003192-19 | Sponsor Protocol Number: ISRCTN11225767 | Start Date*: 2013-02-22 | |||||||||||
Sponsor Name:London School Of Hygiene and Tropical Medicine | |||||||||||||
Full Title: Tranexamic acid for the treatment of gastrointestinal haemorrhage: an international randomised, double blind placebo controlled trial | |||||||||||||
Medical condition: Gastrointestinal hemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) RO (Completed) ES (Prematurely Ended) IE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006102-19 | Sponsor Protocol Number: OM1 | Start Date*: 2008-02-25 | ||||||||||||||||
Sponsor Name:Hospital General Universitario Gregorio Marañón de Madrid | ||||||||||||||||||
Full Title: Tratamiento con omeprazol para la profilaxis de la hemorragia digestiva y el reflujo gastroesofágico en niños críticos Omeprazol treatment for prophylaxis of gastrointestinal bleeding and gastroes... | ||||||||||||||||||
Medical condition: Profilaxis de hemorragia digestiva y prevención del reflujo gastroesofágico en niños críticos | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001077-13 | Sponsor Protocol Number: CICL670A2417 | Start Date*: 2011-08-11 | |||||||||||
Sponsor Name:Novartis Farmacéutica S.A. | |||||||||||||
Full Title: Estudio clínico multicéntrico, aleatorizado, comparativo, de distintos regímenes de administración de deferasirox en la tolerabilidad gastrointestinal (GI), en pacientes con síndrome mielodisplásic... | |||||||||||||
Medical condition: Sobrecarga de hierro de riesgo bajo o intermedio (int-1) en pacientes con síndrome mielodisplásico (SMD) con ferritina > 1000 mcg/L en la selección o antecedentes de transfusión de por lo menos 20 ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001197-18 | Sponsor Protocol Number: NOR-BGT-14-10665 | Start Date*: 2015-05-20 |
Sponsor Name:Biogen Idec Norway | ||
Full Title: The effect of Tecfidera® (Dimethyl Fumarate) on the gut microbiota as a causal factor for GI associated adverse events. | ||
Medical condition: multiple sclerosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-000318-24 | Sponsor Protocol Number: RH-ITA-006 | Start Date*: 2016-08-30 | ||||||||||||||||
Sponsor Name:Dept. of Intensive Care 4131, Copenhagen University Hospital Rigshospitalet | ||||||||||||||||||
Full Title: Stress Ulcer Prophylaxis in the Intensive Care Unit | ||||||||||||||||||
Medical condition: Prophylaxis of stress related gastrointestinal bleeding among critically ill patients in the intensive care unit. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) FI (Completed) NO (Completed) NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-016716-20 | Sponsor Protocol Number: 08/152/WRI | Start Date*: 2010-03-03 | |||||||||||||||||||||
Sponsor Name:Brighton and Sussex University Hospitals NHS Trust | |||||||||||||||||||||||
Full Title: Better targeting of antidepressants in older people: the influence of age and genetic background on serotonin signalling | |||||||||||||||||||||||
Medical condition: Depression | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003339-39 | Sponsor Protocol Number: EHDA-01 | Start Date*: 2017-05-03 | |||||||||||
Sponsor Name:JOSÉ MARÍA PALAZÓN AZORÍN | |||||||||||||
Full Title: A randomized, controlled and double-blind trial of intravenous azithromycin versus intravenous erythromycin as a single dose prior to endoscopy in upper gastrointestinal bleeding | |||||||||||||
Medical condition: Upper gastrointestinal haemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-004588-29 | Sponsor Protocol Number: TA799-101 | Start Date*: 2022-02-01 | ||||||||||||||||||||||||||
Sponsor Name:VectivBio AG | ||||||||||||||||||||||||||||
Full Title: A randomized, single-blind trial to evaluate the safety and efficacy of apraglutide in subjects with Grade II to IV (MAGIC) steroid refractory gastrointestinal (GI) acute graft versus host disease ... | ||||||||||||||||||||||||||||
Medical condition: Acute graft versus host disease (aGVHD) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Trial now transitioned) ES (Ongoing) PT (Prematurely Ended) FR (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-006409-18 | Sponsor Protocol Number: 9463-EC-0002 | Start Date*: 2010-02-09 | ||||||||||||||||
Sponsor Name:Astellas Pharma Europe Ltd. | ||||||||||||||||||
Full Title: An Exploratory Study to Compare the Efficacy and Safety of Micafungin as a Pre-emptive Treatment of Invasive Candidiasis versus Placebo in High Risk Surgical Subjects - A Multicentre, Randomized, D... | ||||||||||||||||||
Medical condition: Invasive Candidiasis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) ES (Completed) HU (Completed) BE (Completed) GR (Completed) DE (Completed) FR (Completed) FI (Completed) IT (Completed) GB (Completed) DK (Completed) NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-005169-20 | Sponsor Protocol Number: Peripheral9000 | Start Date*: 2012-02-14 | |||||||||||
Sponsor Name:Mech-Sense, Department og Gastroenterology, Aalborg Sygehus | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002697-39 | Sponsor Protocol Number: MPOH03 | Start Date*: 2019-01-11 |
Sponsor Name:MaaT Pharma | ||
Full Title: Treatment of steroid refractory gastro-intestinal acute graft-versus-Host disEase afteR AllogeneiC hematopoietic stem celL transplantation with fEcal microbiota transfer (HERACLES) | ||
Medical condition: Steroid refractory gastro-intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) FR (Completed) PL (Prematurely Ended) GB (GB - no longer in EU/EEA) IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003085-12 | Sponsor Protocol Number: ANT-008 | Start Date*: 2022-05-10 |
Sponsor Name:Anthos Therapeutics | ||
Full Title: A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) recurrence and bleeding i... | ||
Medical condition: venous thromboembolism (VTE) in patients with gastrointestinal/genitourinary cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LV (Trial now transitioned) NO (Trial now transitioned) FR (Trial now transitioned) IE (Trial now transitioned) ES (Ongoing) HU (Trial now transitioned) IT (Trial now transitioned) NL (Trial now transitioned) SE (Trial now transitioned) AT (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2004-001234-17 | Sponsor Protocol Number: A3191084 | Start Date*: 2006-06-15 | |||||||||||
Sponsor Name:Pfizer Limited | |||||||||||||
Full Title: Double-blind, triple dummy, parallel-group, randomized, six-month study to compare celecoxib (200 mg BID) with diclofenac SR (75 mg BID) plus omeprazole (20 mg QD) for gastrointestinal events in su... | |||||||||||||
Medical condition: Treatment of osteoarthritis (OA) and/or rheumatoid arthritis (RA) in high GI risk patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) BE (Completed) SE (Completed) CZ (Completed) LT (Completed) DE (Suspended by CA) EE (Completed) PT (Completed) GR (Completed) IE (Completed) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001841-11 | Sponsor Protocol Number: MPOH06 | Start Date*: 2021-11-09 | |||||||||||
Sponsor Name:MaaT Pharma | |||||||||||||
Full Title: Evaluation of the efficacy of MaaT013 as salvage therapy in acute GVHD patients with gastrointestinal involvement, refractory to ruxolitinib; a multi-center open-label phase III trial | |||||||||||||
Medical condition: Salvage therapy of acute GVHD patients with gastrointestinal involvement, refractory to ruxolitinib. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) ES (Ongoing) AT (Trial now transitioned) BE (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
